IKKα kinase silencing increases doxorubicin‐induced apoptosis through regulation of oxidative DNA damage response in colon cancer cells
Authors:
- 27 December 2022
- journal article
- research article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 101 (5) , 1089-1095
Abstract
The inhibitor of kappa B kinase alpha (IKKα) is demonstrated to be involved in the various aspects of cancer biology, from its initiation, to progression, metastasis, and drug resistance. The aim of this study was to investigate the role of IKKα in doxorubicin (DOX)‐mediated induction in apoptosis in SW‐480 colon cancer cells. Cells were transfected with siRNA against IKKα and treated with DOX. MTT assay was applied to measure SW‐480 cell proliferation. The mRNA levels of γ‐H2AX within cells were assessed by qRT‐PCR. 8‐Hydroxy‐2′‐deoxyguanosine was measured by ELISA. The formation of intracellular reactive oxygen species (ROS) was detected by fluorometry. The antioxidant activities of some enzymes were also determined. For evaluation of apoptosis, ELISA assay was applied. IKKα silencing dramatically increased the doxorubicin cytotoxic effects. In addition, IKKα silencing substantially overexpressed γ‐H2AX in SW‐480 cells. Furthermore, upon IKKα silencing, the levels of ROS were elevated and the antioxidant defense system was significantly weakened. In addition, IKKα silencing led to the enhancement of apoptotic cells in doxorubicin‐treated SW‐480 cells. Co‐treatment of IKKα and doxorubicin led to the enhanced cellular cytotoxicity via robosting ROS formation, inducing oxidative DNA damage, and decreasing cellular antioxidant defense, and finally potent apoptosis induction in cancer cell lines.Keywords
This publication has 26 references indexed in Scilit:
- BRAF-induced tumorigenesis is IKKα-dependent but NF-κB–independentScience Signaling, 2015
- Akt and p53R2, partners that dictate the progression and invasiveness of cancerDNA Repair, 2014
- A Truncated Form of IKKα Is Responsible for Specific Nuclear IKK Activity in Colorectal CancerCell Reports, 2012
- Blocking IKKα Expression Inhibits Prostate Cancer InvasivenessPharmaceutical Research, 2010
- IKKα at the Crossroads of Inflammation and MetastasisCell, 2007
- p53 and NF-κB Crosstalk: IKKα Tips the BalanceMolecular Cell, 2007
- Nuclear IKK activity leads to dysregulated Notch-dependent gene expression in colorectal cancerProceedings of the National Academy of Sciences, 2007
- Drug resistance, predictive markers and pharmacogenomics in colorectal cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2006
- IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammationNature, 2005
- Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling PathwayScience, 2001